Quantification of Endocannabinoids in Human Plasma.
2-Arachidonoylglycerol
Endocannabinoids
Liquid chromatography
Liquid-liquid extraction
N-arachidonoylethanolamine
Plasma
Tandem mass spectrometry
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
21
7
2023
pubmed:
19
7
2023
entrez:
18
7
2023
Statut:
ppublish
Résumé
The determination of the concentration of endocannabinoids and related compounds in human plasma has become a matter of interest due to their implication in physiological processes and, thus, their possible relation with physiological conditions or illnesses. The analysis of these compounds though has to be carefully designed as they are found in very low concentrations, and some of them degrade easily once blood is collected. In this chapter, a simple method based on a liquid-liquid extraction and analysis by liquid chromatography tandem mass spectrometry (LC-MS/MS) is described to determine the concentration of eight of the most relevant endocannabinoids in plasma.
Identifiants
pubmed: 37464166
doi: 10.1007/978-1-0716-3307-6_9
doi:
Substances chimiques
Endocannabinoids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107-126Informations de copyright
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Watson JE, Kim JS, Das A (2019) Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. Prostaglandins Other Lipid Mediat 143:106337. https://doi.org/10.1016/j.prostaglandins.2019.106337
doi: 10.1016/j.prostaglandins.2019.106337
pubmed: 31085370
pmcid: 6685292
Tsuboi K, Uyama T, Okamoto Y et al (2018) Endocannabinoids and related N-acylethanolamines: biological activities and metabolism. Inflammation and Regeneration 38:28. https://doi.org/10.1186/s41232-018-0086-5
doi: 10.1186/s41232-018-0086-5
pubmed: 30288203
pmcid: 6166290
Aizpurua-Olaizola O, Elezgarai I, Rico-Barrio I et al (2017) Targeting the endocannabinoid system: future therapeutic strategies. Drug Discov Today 22(1):105–110. https://doi.org/10.1016/j.drudis.2016.08.005
doi: 10.1016/j.drudis.2016.08.005
pubmed: 27554802
Joaquim HPG, Costa AC, Pereira CAC et al (2022) Plasmatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis. Eur J Neurosci 55:1079–1087. https://doi.org/10.1111/ejn.15509
doi: 10.1111/ejn.15509
pubmed: 34716624
Potvin S, Mahrouche L, Assaf R et al (2020) Peripheral endogenous cannabinoid levels are increased in schizophrenia patients evaluated in a psychiatric emergency setting. Front Psych 11:628. https://doi.org/10.3389/fpsyt.2020.00628
doi: 10.3389/fpsyt.2020.00628
Navarrete F, García-Gutiérrez MS, Jurado-Barba R et al (2020) Endocannabinoid system components as potential biomarkers in psychiatry. Front Psych 11:315. https://doi.org/10.3389/fpsyt.2020.00315
doi: 10.3389/fpsyt.2020.00315
Berman P, Sulimani L, Gelfand A et al (2020) Cannabinoidomics – an analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome. Talanta 219:121336. https://doi.org/10.1016/j.talanta.2020.121336
doi: 10.1016/j.talanta.2020.121336
pubmed: 32887067
Seabra G, Falvella ACB, Guest PC et al (2018) Proteomics and lipidomics in the elucidation of endocannabinoid signaling in healthy and schizophrenia brains. Proteomics 18:1700270. https://doi.org/10.1002/pmic.201700270
doi: 10.1002/pmic.201700270
Sempio C, Klawitter J, Jackson M et al (2021) Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography–mass spectrometry. Anal Bioanal Chem 413(12):3381–3392. https://doi.org/10.1007/s00216-021-03280-0
doi: 10.1007/s00216-021-03280-0
pubmed: 33817753
Röhrig W, Achenbach S, Deutsch B et al (2019) Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS. J Lipid Res 60(8):1475–1488. https://doi.org/10.1194/jlr.D094680
doi: 10.1194/jlr.D094680
pubmed: 31235475
pmcid: 6672038
Kratz D, Sens A, Schäfer SMG et al (2022) Pre-analytical challenges for the quantification of endocannabinoids in human serum. J Chromatogr B Anal Technol Biomed Life Sci 1190:123102. https://doi.org/10.1016/j.jchromb.2022.123102
doi: 10.1016/j.jchromb.2022.123102
Shafeeque A, Kalra H, Gupta A et al (2012) HybridSPE: a novel technique to reduce phospholipid-based matrix effect in LC-ESI-MS Bioanalysis. J Pharm BioAllied Sci 4(4):267–275. https://doi.org/10.4103/0975-7406.103234
doi: 10.4103/0975-7406.103234
Gurke R, Thomas D, Schreiber Y et al (2019) Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma – LC-MS/MS method validation and pre-analytical characteristics. Talanta 204:386–394. https://doi.org/10.1016/j.talanta.2019.06.004
doi: 10.1016/j.talanta.2019.06.004
pubmed: 31357310
Oyane A, Kim H-M, Furuya T et al (2003) Preparation and assessment of revised simulated body fluids. J Biomed Mater Res 65A:188–195. https://doi.org/10.1002/jbm.a.10482
doi: 10.1002/jbm.a.10482
Hauer D, Schelling G, Gola H et al (2013) Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS One 8(5):e62741. https://doi.org/10.1371/journal.pone.0062741
doi: 10.1371/journal.pone.0062741
pubmed: 23667516
pmcid: 3647054
González O, Blanco ME, Iriarte G et al (2014) Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect. J Chromatogr A 1353:10–27. https://doi.org/10.1016/j.chroma.2014.03.077
doi: 10.1016/j.chroma.2014.03.077
pubmed: 24794936